pramipexole has been researched along with morphine in 6 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | pramipexole (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kokare, DM; Nakhate, KT; Singh, U; Singru, PS; Subhedar, NK; Upadhya, MA | 1 |
| Brewer, KL; Clemens, S; Dinkins, ML; Lim, SA; Patton, R; Rodgers, HM; Yow, J | 1 |
| Clemens, S; de Castro Brás, LE; Dinkins, ML; Gaweda, G; Grilo, GA; Iyer, RP; Shaver, PR; Stoffel, HJ | 1 |
1 review(s) available for pramipexole and morphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for pramipexole and morphine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine.
Topics: Animals; Benzothiazoles; Dopamine; Dopamine Agonists; Male; Morphine; Narcotics; Nerve Tissue Proteins; Neurons; Nucleus Accumbens; Pramipexole; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Signal Transduction | 2012 |
Dopamine D
Topics: Analgesia; Analgesics, Opioid; Animals; Chronic Pain; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Drug Tolerance; Female; Male; Mice; Mice, Inbred C57BL; Morphine; Neuralgia; Pramipexole; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D3; Substance Withdrawal Syndrome | 2020 |
Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosis.
Topics: Animals; Collagen; Fibrosis; Hypertrophy; Male; Mice, Inbred C57BL; Morphine; Myocardium; Myocytes, Cardiac; Pramipexole; Receptors, Dopamine D3; Systole | 2020 |